Partner Network Growth StemGenex is a physician-led regenerative medicine provider offering adipose-derived stem cell therapy for inflammatory and degenerative diseases. The physician-led model makes it suitable for aligning with clinics, hospitals, and specialist groups to refer patients or co-deliver services. This creates sales opportunities to build a B2B referral network, white-label offerings, or joint marketing agreements to capture growing demand for non-surgical regenerative therapies.

Expanded Therapeutic Scope Current therapy roster covers MS, Parkinson's, RA, COPD, OA, indicating a broad degenerative/inflammatory focus. There is opportunity to broaden conditions with strong patient populations and create case studies and clinician education to support uptake. Engage patient advocacy groups, insurers, and employer-based health plans to drive coverage discussions and access programs, expanding the addressable market.

Digital Acquisition Optimization StemGenex has a robust digital stack (analytics, tracking pixels, SEO). This enables data-driven optimization of patient acquisition. A focused BD play includes optimizing landing pages, retargeting medical inquiries, and building content targeting degenerative disease communities to improve conversion rates and reduce CAC. Consider co-branded marketing programs with clinics and patient groups to maximize ROI.

Geographic Expansion With a San Diego base and 11-50 employees, there is potential to scale regionally and nationally by pursuing state-by-state registrations, partnerships with local clinics, and telemedicine-enabled follow-up care. Target markets with high demand for regenerative therapies and favorable regulatory environments; develop a scalable clinic network and national patient services for remote intake and post-treatment monitoring.

Research Partnerships As a recognized leader in US regenerative medicine, StemGenex can monetize through research collaborations, clinical trials, and data licensing with universities, CROs, and biotech partners. Opportunities include joint trials, sponsored studies, and white-label or licensing arrangements for processing protocols, manufacturing, or outcome data analytics, strengthening competitive positioning.